glp-1 nausea class action in michigan FDA warns Ozempic and Wegovy maker over unreported side effects Ozempic Lawsuit – July 2026
Description
From supermarket shelves to farm fields, everything shifts when calories fall and quality rises
Years after approving three glucagon-like peptide-1 (GLP-1) receptor agonists to treat obesity, the U.S
It is NOT intended for human or veterinary use, consumption, diagnostics, therapeutic applications, or any other use outside of controlled laboratory research
Listen in to hear about GLP-1 history and the results of our office taste test while mimicking reduced appetite
However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors
Do not use it if the safety seal is broken or missing
